CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis
By Elana Gotkine HealthDay Reporter
MONDAY, March 24, 2025 -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study published online March 20 in JAMA Network Open.
Anna Jo Bodurtha Smith, M.D., M.P.H., from the University of Pennsylvania Health Systems in Philadelphia, and colleagues conducted a retrospective cohort study involving all patients with ovarian cancer diagnosed between Jan. 1, 2004, and Dec. 31, 2020, to examine CA-125 levels at ovarian cancer diagnosis by patient race and ethnicity.
Of the 250,749 patients included, 0.4, 3.7, 8.6, 85.2, and 2.0 percent were American Indian, Asian, Black, White, and other or unknown race, respectively, and 6.7, 88.8, and 4.6 percent were Hispanic, non-Hispanic, and unknown ethnicity, respectively. Overall, 212,477 had measured CA-125 levels and 88.2 percent had elevated CA-125 levels at diagnosis. The researchers found that the likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for patients of American Indian, Asian, or Black race versus White patients. After adjustment for stage, comorbidities, and menopausal stage, Black and American Indian patients had lower odds of elevated CA-125 than Whites (adjusted odds ratios, 0.77 and 0.77). For patients with high-grade serous ovarian cancer only, the odds of having elevated CA-125 at diagnosis were lower for Black patients (adjusted odds ratio, 0.81).
"Further work is needed to develop inclusive CA-125 thresholds and guidelines for an ovarian cancer diagnosis and prevent compounding disparities," the authors write.
One author disclosed ties to GlaxoSmithKline.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'
WEDNESDAY, June 18, 2025 -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will...
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
WEDNESDAY, June 18, 2025 -- Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July...
Virtual Reality Training Module May Aid Infection Control Efforts
TUESDAY, June 17, 2025 -- Users report positive experiences and engagement with a virtual reality tool that trains clinicians on core concepts in infection control, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.